piracetam has been researched along with methylphenidate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Butler, DE; L'Italien, YJ; Marriott, JG; Nordin, IC; Poschel, PH; Zweisler, L | 1 |
Caltagirone, C; David, P; Macchi, G; Rossini, PM | 1 |
Jones, RS; Olpe, HR; Steinmann, MW | 1 |
Baiguerra, G; Giraud, O; Valzelli, L | 1 |
Gershon, S; Goodnick, P | 1 |
Ferris, SH; Gershon, S; Reisberg, B | 1 |
Fond, G; MacGregor, A; Micoulaud-Franchi, JA | 1 |
Chrzanowski, Ł; Corvini, PF; Wilms, W; Woźniak-Karczewska, M | 1 |
Bertoldi, AD; de Oliveira Cata Preta, B; Miranda, VIA | 1 |
3 review(s) available for piracetam and methylphenidate
Article | Year |
---|---|
Chemotherapy of cognitive disorders in geriatric subjects.
Topics: Adrenocorticotropic Hormone; Aged; Aging; Alzheimer Disease; Arecoline; Brain Chemistry; Choline; Cognition Disorders; Cyclandelate; Electroencephalography; Humans; Memory; Methylphenidate; Pentylenetetrazole; Phosphatidylcholines; Physostigmine; Piracetam; Procaine; Vasodilator Agents; Vasopressins | 1984 |
An overview of pharmacologic treatment of cognitive decline in the aged.
Topics: Anticoagulants; Clinical Trials as Topic; Cognition Disorders; Dihydroergotoxine; Humans; Hyperbaric Oxygenation; Methylphenidate; Parasympathomimetics; Peptides; Piracetam; Procaine; Vasodilator Agents | 1981 |
Nootropic drugs: Methylphenidate, modafinil and piracetam - Population use trends, occurrence in the environment, ecotoxicity and removal methods - A review.
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Environmental Pollutants; Humans; Memory; Methylphenidate; Modafinil; Nootropic Agents; Piracetam; Wastewater | 2019 |
2 trial(s) available for piracetam and methylphenidate
Article | Year |
---|---|
Jakob-Creutzfeldt disease: analysis of EEG and evoked potentials under basal conditions and neuroactive drugs.
Topics: Aged; Cerebral Cortex; Clinical Trials as Topic; Creutzfeldt-Jakob Syndrome; Diazepam; Electroencephalography; Evoked Potentials; Humans; Injections, Intravenous; Methylphenidate; Piracetam; Placebos; Pyrrolidinones | 1979 |
An overview of pharmacologic treatment of cognitive decline in the aged.
Topics: Anticoagulants; Clinical Trials as Topic; Cognition Disorders; Dihydroergotoxine; Humans; Hyperbaric Oxygenation; Methylphenidate; Parasympathomimetics; Peptides; Piracetam; Procaine; Vasodilator Agents | 1981 |
5 other study(ies) available for piracetam and methylphenidate
Article | Year |
---|---|
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
Topics: Amnesia; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Humans; Male; Mice; Mice, Inbred Strains; Pyrrolidines; Structure-Activity Relationship | 1984 |
Locus coeruleus as a target for psychogeriatric agents.
Topics: Amphetamine; Animals; Caffeine; Cerebral Cortex; Dihydroergotoxine; Dose-Response Relationship, Drug; Learning; Locus Coeruleus; Male; Memory; Methylphenidate; Neural Pathways; Neurons; Piracetam; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Septum Pellucidum; Vincamine | 1985 |
Difference in learning and retention by Albino Swiss mice. Part III. Effect of some brain stimulants.
Topics: Animals; Autonomic Agents; Caffeine; Learning; Male; Memory; Methylphenidate; Mice; Nicotine; Piperazines; Piracetam; Pyrrolidines | 1986 |
A preliminary study on cognitive enhancer consumption behaviors and motives of French Medicine and Pharmacology students.
Topics: Adolescent; Adult; Ascorbic Acid; Benzhydryl Compounds; Caffeine; Education, Medical; Female; France; Humans; Illicit Drugs; Male; Methamphetamine; Methylphenidate; Modafinil; Nootropic Agents; Pharmacology; Piracetam; Prevalence; Students, Health Occupations; Surveys and Questionnaires; Young Adult | 2014 |
Psychostimulant Use for Neuroenhancement (Smart Drugs) among College Students in Brazil.
Topics: Brazil; Central Nervous System Stimulants; Cognition; Cross-Sectional Studies; Humans; Methylphenidate; Modafinil; Pharmaceutical Preparations; Piracetam; Students; Substance-Related Disorders; Universities | 2020 |